Cambridge Investment Research Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-996
| Closed | -$8K | – | 3321 |
|
|
2023
Q1 | $8K | Sell |
996
-4
| -0.4% | -$32 | ﹤0.01% | 3137 |
|
|
2022
Q4 | $12K | Buy |
1,000
+81
| +9% | +$972 | ﹤0.01% | 3073 |
|
|
2022
Q3 | $13K | Hold |
919
| – | – | ﹤0.01% | 3017 |
|
|
2022
Q2 | $32K | Hold |
919
| – | – | ﹤0.01% | 2974 |
|
|
2022
Q1 | $37K | Sell |
919
-7
| -0.8% | -$282 | ﹤0.01% | 3097 |
|
|
2021
Q4 | $39K | Hold |
926
| – | – | ﹤0.01% | 3114 |
|
|
2021
Q3 | $63K | Hold |
926
| – | – | ﹤0.01% | 3010 |
|
|
2021
Q2 | $71K | Buy |
926
+85
| +10% | +$6.52K | ﹤0.01% | 3002 |
|
|
2021
Q1 | $55K | Buy |
841
+143
| +20% | +$9.35K | ﹤0.01% | 2803 |
|
|
2020
Q4 | $24K | Buy |
698
+29
| +4% | +$997 | ﹤0.01% | 2677 |
|
|
2020
Q3 | $37K | Buy |
+669
| New | +$37K | ﹤0.01% | 2466 |
|
|
2019
Q1 | – | Sell |
-229
| Closed | -$36K | – | 2359 |
|
|
2018
Q4 | $36K | Buy |
+229
| New | +$36K | ﹤0.01% | 2105 |
|